Oseltamivir (German Wikipedia)

Analysis of information sources in references of the Wikipedia article "Oseltamivir" in German language version.

refsWebsite
Global rank German rank
2nd place
3rd place
1st place
1st place
4th place
7th place
1,226th place
1,116th place
195th place
255th place
low place
1,888th place
low place
6,801st place
3,538th place
1,951st place
234th place
203rd place
924th place
87th place
458th place
30th place
1,071st place
60th place
201st place
11th place
3,043rd place
200th place
1,476th place
1,995th place
1,248th place
2,191st place
1,065th place
65th place
4,845th place
310th place
753rd place
43rd place
low place
low place
673rd place
56th place
66th place
4th place
68th place
29th place
2,194th place
170th place
226th place
12th place

acs.org

pubs.acs.org

aerzteblatt.de

arznei-telegramm.de

bayern.de

orh.bayern.de

bmj.com

doi.org

  • H. J. Schünemann, S. R. Hill, M. Kakad et al.: WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. In: Lancet Infect Dis. 7. Jahrgang, Nr. 1, Januar 2007, S. 21–31, doi:10.1016/S1473-3099(06)70684-3, PMID 17182341.
  • Tom Jefferson, Mark A Jones, Peter Doshi et al.: Neuraminidase inhibitors for preventing and treating influenza in healthy adults and children. In: British Medical Journal. 2014, Online-Vorabveröffentlichung vom 10. April 2014, doi:10.1002/14651858.CD008965.pub4.
  • T. Jefferson, V. Demicheli, D. Rivetti, M. Jones, C. Di Pietrantonj, A. Rivetti: Antivirals for influenza in healthy adults: systematic review. In: Lancet. Band 367, Nummer 9507, Januar 2006, S. 303–313, doi:10.1016/S0140-6736(06)67970-1, PMID 16443037 (Review).
  • Toshihiro Tanaka et al.: Safety of neuraminidase inhibitors against novel influenza A (H1N1) in pregnant and breastfeeding women. In: Canadian Medical Association Journal. 2009, Band 181, Nr. 1–2, S. 55–58, doi:10.1503/cmaj.090866.
  • T Mita, N Fukuda, FX Roca, M Kanai, M Shibasaki: Second generation catalytic asymmetric synthesis of Tamiflu: allylic substitution route. In: Org. Lett. 9. Jahrgang, Nr. 2, Januar 2007, S. 259–262, doi:10.1021/ol062663c, PMID 17217279.
  • Satoh N, Akiba T, Yokoshima S, Fukuyama T: A practical synthesis of (−)-oseltamivir. In: Angew. Chem. Int. Ed. Engl. 46. Jahrgang, Nr. 30, 2007, S. 5734–5736, doi:10.1002/anie.200701754, PMID 17594704 (pitt.edu [PDF]).
  • BM Trost, T Zhang: A concise synthesis of (−)-oseltamivir. In: Angew. Chem. Int. Ed. Engl. 47. Jahrgang, Nr. 20, 2008, S. 3759–3761, doi:10.1002/anie.200800282, PMID 18399551.
  • Ying-Yeung Yeung, Sungwoo Hong, E. J. Corey: A Short Enantioselective Pathway for the Synthesis of the Anti-Influenza Neuramidase Inhibitor Oseltamivir from 1,3-Butadiene and Acrylic Acid. In: J. Am. Chem. Soc., 2006, 128(19), S. 6310–6311; (Communication) doi:10.1021/ja0616433.
  • N. J. Dharan, L. V. Gubareva, J. J. Meyer et al.: Infections With Oseltamivir-Resistant Influenza A(H1N1) Virus in the United States. In: JAMA. 2. März 2009, Band 301, Nr. 10, doi:10.1001/jama.2009.294.
  • Tamiflu: the battle for secret drug data In: British Medical Journal. 2012, Band 345, e7303, doi:10.1136/bmj.e7303.
  • F. Godlee, M. Clarke: Why don’t we have all the evidence on oseltamivir?. In: BMJ. Band 339, 2009, S. b5351–b5351, doi:10.1136/bmj.b5351.

eurekalert.org

  • eurekalert.org vom 17. Januar 2012: Continuing uncertainties surround anti-influenza drug.
  • eurekalert.org vom 17. Januar 2012: Effects of Tamiflu still uncertain, warn experts, as Roche continues to withhold key trial data.

europa.eu

ema.europa.eu

eurosurveillance.org

  • A. Wallenstein et al.: Compliance and side effects of prophylactic oseltamivir treatment in a school in South West England. In: Eurosurveillance. Band 14, Nr. 30, 2009, Volltext.

handelsblatt.com

n-tv.de

nature.com

blogs.nature.com

  • nature.com vom 13. Januar 2012: Researchers renew fight with Roche over flu drug evidence.

nature.com

nih.gov

ncbi.nlm.nih.gov

  • H. J. Schünemann, S. R. Hill, M. Kakad et al.: WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus. In: Lancet Infect Dis. 7. Jahrgang, Nr. 1, Januar 2007, S. 21–31, doi:10.1016/S1473-3099(06)70684-3, PMID 17182341.
  • T. Jefferson, V. Demicheli, D. Rivetti, M. Jones, C. Di Pietrantonj, A. Rivetti: Antivirals for influenza in healthy adults: systematic review. In: Lancet. Band 367, Nummer 9507, Januar 2006, S. 303–313, doi:10.1016/S0140-6736(06)67970-1, PMID 16443037 (Review).
  • T Mita, N Fukuda, FX Roca, M Kanai, M Shibasaki: Second generation catalytic asymmetric synthesis of Tamiflu: allylic substitution route. In: Org. Lett. 9. Jahrgang, Nr. 2, Januar 2007, S. 259–262, doi:10.1021/ol062663c, PMID 17217279.
  • Satoh N, Akiba T, Yokoshima S, Fukuyama T: A practical synthesis of (−)-oseltamivir. In: Angew. Chem. Int. Ed. Engl. 46. Jahrgang, Nr. 30, 2007, S. 5734–5736, doi:10.1002/anie.200701754, PMID 17594704 (pitt.edu [PDF]).
  • BM Trost, T Zhang: A concise synthesis of (−)-oseltamivir. In: Angew. Chem. Int. Ed. Engl. 47. Jahrgang, Nr. 20, 2008, S. 3759–3761, doi:10.1002/anie.200800282, PMID 18399551.
  • Le Qm et al.: Avian flu, isolation of drug-resistant H5N1 virus. In: Nature, London 2005, Band 437, Nr. 7062, 20. Oktober, S. 1108, PMID 16228009.

pitt.edu

ccc.chem.pitt.edu

rki.de

roche.com

sigmaaldrich.com

spiegel.de

sueddeutsche.de

tagesanzeiger.ch

tagesspiegel.de

taz.de

web.archive.org

welt.de

  • welt.de vom 18. Januar 2012: Tamiflu hat schwerere Nebenwirkungen als gedacht.

who.int